Ten years' experience with intraoperative MRI-assisted transsphenoidal pituitary surgery

Neurosurg Focus. 2020 Jun;48(6):E14. doi: 10.3171/2020.3.FOCUS2072.

Abstract

Objective: Many innovations have been introduced into pituitary surgery in the quest to maximize the extent of tumor resection. Because of the deep and narrow surgical corridor as well as the heterogeneity of confronted pathologies, anatomical orientation and identification of the target tissue can become difficult. Intraoperative MRI (iMRI) may have the potential to increase extent of resection (EOR) in transsphenoidal pituitary surgery. Furthermore, it may simplify anatomical orientation and risk assessment in difficult cases. Here, the authors evaluated the additional value of iMRI for the resection of pituitary adenomas performed in the past 10 years in their department.

Methods: They performed a retrospective single-center analysis of patients treated for pituitary adenoma in their department after the introduction of iMRI between 2008 and 2018. Of 495 transsphenoidal approaches, 300 consecutive MRI-assisted surgeries for pituitary adenomas encompassing 294 patients were selected for further analysis. Microscopic, endoscopic, or endoscope-assisted microscopic transsphenoidal approaches were distinguished. EOR as well as additional resection following iMRI was evaluated via detailed volumetric analysis. Patients were stratified according to the Knosp adenoma classification. Furthermore, demographic data, clinical symptoms, endocrine outcome, and complications were evaluated. Univariable and multivariable Cox regression analyses of progression-free survival (PFS) were performed.

Results: Pituitary adenomas classified as Knosp grades 0-2 were found in 60.3% of cases (n = 181). The most common tumors were nonfunctioning adenomas (75%). Continued resection following iMRI significantly increased EOR (7.5%, p < 0.001) and the proportion of gross-total resections (GTRs) in transsphenoidal pituitary surgery (54% vs 68.3%, p < 0.001). Additional resection after iMRI was performed in 37% of cases. Only in the subgroup of patients with Knosp grades 0-2 adenomas treated with the microsurgical technique was additional resection significantly more common than in the endoscopic group (p = 0.039). Residual tumor volume, Knosp grade, and age were confirmed as independent predictors of PFS (p < 0.001, p = 0.021, and p = 0.029, respectively) in a multivariable Cox regression analysis. Improvement of visual field deficits was documented in 78.6% of patients whose optic apparatus had been affected preoperatively. Revision surgery was done in 7.3% of cases; in 5.6% of cases, it was performed for cerebrospinal fluid fistula.

Conclusions: In this series, iMRI led to the detection of a resectable tumor remnant in a high proportion of patients, resulting in a greater EOR and higher proportion of GTRs after continued resection in microsurgical and endoscopic transsphenoidal resection of pituitary adenomas. The volume of residual tumor was the most important predictor of PFS. Given the study data, the authors postulated that every bit of removed tumor serves the patient and increases their chances of a favorable outcome.

Keywords: CSF = cerebrospinal fluid; DI = diabetes insipidus; EOR = extent of resection; GH = growth hormone; GTR = gross-total resection; PFS = progression-free survival; ROC = receiver operating characteristic; endoscopic technique; extent of resection; iMRI = intraoperative MRI; intraoperative MRI; microscopic technique; progression-free survival; transsphenoidal pituitary surgery.

MeSH terms

  • Adenoma / diagnostic imaging
  • Adenoma / surgery*
  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Humans
  • Intraoperative Neurophysiological Monitoring / methods
  • Intraoperative Neurophysiological Monitoring / trends*
  • Magnetic Resonance Imaging / methods
  • Magnetic Resonance Imaging / trends*
  • Male
  • Middle Aged
  • Neuroendoscopy / methods
  • Neuroendoscopy / trends*
  • Pituitary Neoplasms / diagnostic imaging
  • Pituitary Neoplasms / surgery*
  • Retrospective Studies
  • Sphenoid Bone / diagnostic imaging
  • Sphenoid Bone / surgery*
  • Time Factors
  • Treatment Outcome
  • Tumor Burden / physiology